H2020Individual fellowship2019–2020

TCELLTIGIT · Structural characterization of immune signaling protein TIGIT using x-ray crystallography and cryo-electron microscopy

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2019-01-01 → 2020-12-31
EU contribution
€175,866
Participants
1
Scheme
MSCA-IF

Lines connect the coordinator with its partners.

Results in brief

Structural characterization of immune signaling protein TIGIT using x-ray crystallography and cryo-electron microscopy

Immunosignaling proteins are the target of anti-cancer and anti-viral immunotherapies. These proteins are known as single pass transmembrane receptors and consist of 3 parts: an extracellular domain (ECD), a transmembrane (TM) domain, and an intracellular domain (ICD). The TM domain is important because it allows signals to be transferred from the outside of the cell to the inside through the cell membrane. However, very little is known about the TM domains of these proteins because no structures have been solved that include this domain. The objective of this project was to solve a structure of the immunosignaling protein TIGIT (T cell immunoreceptor with Ig and ITIM domains) that contains the TM domain. The goal of this was to allow us to better understand how these immunosignaling proteins conduct signals through the cell membrane. Understanding the mechanism for how these protein conduct signals through the membrane bilayer is important because it could potentially result in the design of new anti-cancer and anti-viral immunotherapies targeting the TM domains of these proteins. However, the action was terminated early due to medical issues experienced by the fellow, so we note that not all of the objectives of the action could be accomplished given the circumstances.

Data: CORDIS, © European Union

Project objective

The goal of this proposal is to obtain atomic resolution structures of TIGIT using X-ray crystallography and cryo-electron microscopy. TIGIT inhibits autoimmune responses, and anti-TIGIT antibodies can induce immune response in anti-viral and anti-tumor immunotherapies. No structures exist for the transmembrane (TM) domain of TIGIT, which is the portion of the signaling protein that transmits signals accross the membrane bilayer, and there are no structures of TIGIT bound to anti-TIGIT antibodies. High-resolution structures of full-length TIGIT and TM domain constructs will further our understanding of how TIGIT transmits signals across the cell membrane and modulates T cell activation. Structures of TIGIT TM constructs bound to PVR and anti-TIGIT antibodies will guide the design of anti-TIGIT drugs and antibodies for use in immunotherapy treatments. The candidate will carry out this structural work in the lab of Prof. Martin Caffrey, a world- renowned leader in the field of membrane protein X-ray crystallography.

Original text from CORDIS.

Participants

  • THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN · DublinCoordinatorIreland

Links

Data: CORDIS, © European Union